Ulcerative Colitis Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research Global Ulcerative Colitis Market, By Type (Ulcerative Proctitis, Proctosigmoiditis, Left-Sided Colitis, Pan Colitis or Universal Colitis, and Fulminant Colitis), Drug Type (Anti-Inflammatory Drugs, Amino salicylates, Corticosteroids, Anti-TNF biologics, Immunosuppressant, Calcineurin Inhibitors and Other), Molecule Type (Small Molecules and Biologics), Route of Administration (Injectable and Oral), End User (Hospital Pharmacies, Retail Pharmacies, Drug Store and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028